Medtech Giant Edwards Top Sales Views, But Slips On In-Line Profit

Medtech giant Edwards Lifesciences (EW) reported in-line profit late Tuesday and a narrow sales beat for the fourth quarter. But EW stock slumped in late trades. During the fourth quarter, sales grew 14% to $1.53 billion. Excluding the impact of exchange rates, sales rose 13%. Analysts expected a…#medtech #edwardslifesciences #eps #marketsmithcom #allisongatlin #ibdagatlin
Source: Reuters: Health - Category: Consumer Health News Source Type: news